BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 5, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 15, 2009
View Archived Issues
Adenoviral delivery of alpha-sarcoglycan may be a promising therapy for muscular dystrophy
Read More
Botulinum toxin type B safe over 7 years in patients with cervical dystonia
Read More
Glycopyrronium bromide significantly improves sialorrhea in Parkinson's disease patients
Read More
AstraZeneca discloses novel prostaglandin E synthase-1 inhibitors for osteoarthritis therapy
Read More
Schering-Plough describes RNA-directed RNA polymerase inhibitors for the treatment of hepatitis C
Read More
Cis-urocanic acid emulsion improves skin barrier function in acute irritant dermatitis phase I study
Read More
DMMET-01 improves metabolic control in naive type 2 diabetes patients
Read More
3-Month extension of review period expected for Intermezzo NDA
Read More
Millennium Pharmaceuticals claims IKK-2 inhibitors for the treatment of rheumatoid arthritis
Read More
Bristol-Myers Squibb describes NS5B polymerase inhibitors for HCV
Read More
RGI-2001 in combination with low-dose sirolimus induces donor-specific transplantation tolerance
Read More
AEterna opens extended study for cetrorelix in benign prostatic hyperplasia
Read More
Cytos initiates combined phase I/IIa study with anti-interleukin-1 beta vaccine
Read More
Caldolor is first FDA approved intravenous therapy for fever
Read More
ImmunoGen seeks to outlicense discontinued compound IMGN-242
Read More
Modigene approves company name change to Prolor Biotech
Read More
Abraxane now available in China
Read More
Xenon and Merck & Co. establish cardiovascular strategic alliance
Read More
Takeda presents 5-HT2C receptor agonists for the treatment of obesity
Read More
G-15, a highly selective GRP30 antagonist, may be useful in the regulation of estrogen signaling
Read More
Genzyme receives European approval of Renvela for chronic kidney disease
Read More
Icagen completes enrollment in phase II senicapoc trial in exercise-induced asthma
Read More
FDA expected to approve REMS for Meda's cancer pain drug Onsolis in summer 2009
Read More
Merck & Co. to update prescribing information for Singulair following FDA communication
Read More
BSI and Lohocla sign licensing agreement for alcoholism liver disease biomarkers
Read More
Archimedes and Almac sign licensing and development agreement for granisetron product
Read More
St. Jude Medical to sponsor CABANA trial of catheter ablation in atrial fibrillation
Read More